Shortage of methylphenidate hydrochloride modified-release tablets

We have been notified about current and anticipated shortages of Concerta and Methylphenidate-Teva XR modified-release methylphenidate hydrochloride tablet products. 

These medicines are used to treat attention deficit hyperactivity disorder (ADHD).

We acknowledge the concerns and difficulties caused by such shortages, especially due to the specific requirements for prescribing and dispensing methylphenidate hydrochloride. We hope this early notification will give patients and prescribers the opportunity to plan ahead.

We urge patients who will be affected by these shortages to speak with their pharmacist about their supply of medicines. We also suggest patients consult with their prescribers early about their treatment plan, as they may need a new prescription and it may be difficult to make appointments over the holiday season.

Please note that other forms of methylphenidate medicines, such as immediate-release tablets and modified-release capsules, remain available. Other medicines approved to treat ADHD are also available.

Please go to About the shortage of methylphenidate hydrochloride modified-release tablets for more information. 

You can also go to the Medicine Shortage Reports Database- external site - external site (search for ‘methylphenidate’) for the most up-to-date information.